These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 14583578)
1. Experience with infliximab (anti-TNF alpha monoclonal antibody) as monotherapy for giant cell arteritis. Andonopoulos AP; Meimaris N; Daoussis D; Bounas A; Giannopoulos G Ann Rheum Dis; 2003 Nov; 62(11):1116. PubMed ID: 14583578 [No Abstract] [Full Text] [Related]
2. Infliximab as monotherapy in giant cell arteritis. Uthman I; Kanj N; Atweh S Clin Rheumatol; 2006 Feb; 25(1):109-10. PubMed ID: 15902519 [No Abstract] [Full Text] [Related]
3. Anti-tumour necrosis factor treatment with infliximab in a case of giant cell arteritis resistant to steroid and immunosuppressive drugs. Airò P; Antonioli CM; Vianelli M; Toniati P Rheumatology (Oxford); 2002 Mar; 41(3):347-9. PubMed ID: 11934977 [No Abstract] [Full Text] [Related]
4. Infliximab efficiency and failure. Rozin AP Ann Rheum Dis; 2004 Jun; 63(6):751-2; author reply 752. PubMed ID: 15140791 [No Abstract] [Full Text] [Related]
5. Treatment of longstanding active giant cell arteritis with infliximab: report of four cases. Cantini F; Niccoli L; Salvarani C; Padula A; Olivieri I Arthritis Rheum; 2001 Dec; 44(12):2933-5. PubMed ID: 11762955 [No Abstract] [Full Text] [Related]
6. [Infliximab is ineffective against giant cell arteritis and polymyalgia rheumatica]. Krüger K Z Rheumatol; 2007 Oct; 66(6):536-7. PubMed ID: 17849125 [No Abstract] [Full Text] [Related]
7. Summaries for patients. Adding infliximab to the treatment regimen for giant cell arteritis. Ann Intern Med; 2007 May; 146(9):I12. PubMed ID: 17470826 [No Abstract] [Full Text] [Related]
8. [Improvement in visual acuity in a patient with ischaemic optic neuropathy (Horton arteritis) undergoing therapy with infliximab: a case report]. Benucci M; Manfredi M; Puce F; Zuccarini S Recenti Prog Med; 2007 Dec; 98(12):624-6. PubMed ID: 18369037 [TBL] [Abstract][Full Text] [Related]
9. Treatment of refractory temporal arteritis with adalimumab. Ahmed MM; Mubashir E; Hayat S; Fowler M; Berney SM Clin Rheumatol; 2007 Aug; 26(8):1353-5. PubMed ID: 16944071 [TBL] [Abstract][Full Text] [Related]
10. Anti-CD20 monoclonal antibody (rituximab) as an adjunct in the treatment of giant cell arteritis. Bhatia A; Ell PJ; Edwards JC Ann Rheum Dis; 2005 Jul; 64(7):1099-100. PubMed ID: 15958774 [No Abstract] [Full Text] [Related]
11. How is infliximab harmful? Arkfeld DG Ann Intern Med; 2008 Jan; 148(2):166; author reply 166. PubMed ID: 18195344 [No Abstract] [Full Text] [Related]
12. Interleukin 6 blockade as steroid-sparing treatment for 2 patients with giant cell arteritis. Sciascia S; Rossi D; Roccatello D J Rheumatol; 2011 Sep; 38(9):2080-1. PubMed ID: 21885526 [No Abstract] [Full Text] [Related]
13. Interleukin-1 blockade in refractory giant cell arteritis. Ly KH; Stirnemann J; Liozon E; Michel M; Fain O; Fauchais AL Joint Bone Spine; 2014 Jan; 81(1):76-8. PubMed ID: 23890680 [TBL] [Abstract][Full Text] [Related]
14. Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis. Finckh A; Simard JF; Gabay C; Guerne PA; Ann Rheum Dis; 2006 Jun; 65(6):746-52. PubMed ID: 16339288 [TBL] [Abstract][Full Text] [Related]